Editas Medicine: Q1 Earnings Insights


Editas Medicine EDIT reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.


Editas Medicine beat estimated earnings by 6.33%, reporting an EPS of $-0.74 versus an estimate of $-0.79.

Revenue was up $272.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.11 which was followed by a 6.56% increase in the share price the next day.

Here's a look at Editas Medicine's past performance:


Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.72 -0.82 -0.83 -0.75
EPS Actual -0.61 -0.57 -0.81 -0.86
Revenue Estimate 4.29M 4.78M 6.17M 5.14M
Revenue Actual 12.47M 6.20M 379.00K 6.50M

To track all earnings releases for Editas Medicine visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!